The effect of sequential radiochemotherapy in preirradiated malignant gliomas in a phase II study

Journal of Neuro-Oncology

Volumn 67, Issue 1-2, 2004, Pages 233-239

  Schäfer, Ulrich ^a   Micke, Oliver ^a   Schüller, Patrick ^a   Schuck, Andreas ^a   Willich, Normann ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Malignant gliomas; Radiochemotherapy; Reirradiation

Indexed keywords

ANTICONVULSIVE AGENT; ANTIEMETIC AGENT; CORTICOSTEROID; STEROID; TEMOZOLOMIDE;

ACUTE DISEASE; ADULT; AGE; AGED; BLOOD TOXICITY; CANCER CHEMOTHERAPY; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEATH; DISEASE SEVERITY; DRUG DOSE REGIMEN; FEASIBILITY STUDY; GLIOBLASTOMA; HEADACHE; HUMAN; HUMAN TISSUE; LEUKOPENIA; MENTAL DEFICIENCY; PHASE 2 CLINICAL TRIAL; PROSPECTIVE STUDY; RADIATION DOSE; REVIEW; STANDARDIZATION; SURVIVAL TIME; THROMBOCYTOPENIA; TREATMENT PLANNING; TUMOR GROWTH;

ADULT; AGED; ANTINEOPLASTIC AGENTS, ALKYLATING; BRAIN NEOPLASMS; COMBINED MODALITY THERAPY; DACARBAZINE; GLIOMA; HUMANS; MIDDLE AGED; PROSPECTIVE STUDIES; RADIOTHERAPY; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 1842431900     PISSN: 0167594X     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:NEON.0000021898.31923.bd     Document Type: Review

References (52)

1. Liang BC, Thornton AF Jr, Sandler HM, Greenberg HS: Malignant astrocytomas: focal tumor recurrence after focal external beam radiation therapy. J Neurosurg 75: 559-563, 1991
2. Wallner KE, Galicich JH, Krol G, Arbit E, Malkin MG: Patterns of failure following treatment for glioblastoma multiforme and anaplastic astrocytoma. Int J Radiat Oncol Biol Phys 16: 1405-1409, 1989
3. Brandes AA, Fiorentino MV: The role of chemotherapy in recurrent malignant gliomas: an overview. Cancer Invest 14: 551-559, 1996
4. Brandes AA, Vastola F, Monfardini S: Reoperation in recurrent high-grade gliomas: literature review of prognostic factors and outcome. Am J Clin Oncol 22: 387-390, 1999
5. Voynov G, Kaufman S, Hong T, Pinkerton A, Simon R, Dowsett R: Treatment of recurrent malignant gliomas with stereotactic intensity modulated radiation therapy. Am J Clin Oncol 25: 606-611, 2002
6. Gutin PH, Leibel SA, Hosobuchi Y, Crumley RL, Edwards MS, Wilson CB, Lamb S, Weaver KA: Brachytherapy of recurrent tumors of the skull base and spine with iodine-125 sources. Neurosurgery 20: 938-945, 1987
7. Sheline GE, Wara WM, Smith V: Therapeutic irradiation and brain injury. Int J Radiat Oncol Biol Phys 6: 1215-1228, 1980
8. Huncharek M, Muscat J: Treatment of recurrent high grade astrocytoma; results of a systematic review of 1,415 patients. Anticancer Res 18: 1303-1311, 1998
9. Levin VA, Prados MD: Treatment of recurrent gliomas and metastatic brain tumors with a polydrug protocol designed to combat nitrosourea resistance. J Clin Oncol 10: 766-771, 1992
10. Yung WK, Mechtler L, Gleason MJ: Intravenous carboplatin for recurrent malignant glioma: a phase II study. J Clin Oncol 9: 860-864, 1991
11. Brandes AA, Pasetto LM, Vastola F, Monfardini S: Temozolomide in patients with high grade gliomas. Oncology 59: 181-186, 2000
12. Yung WK, Albright RE, Olson J, Fredericks R, Fink K, Prados MD, Brada M, Spence A, Hohl RJ, Shapiro W, Glantz M, Greenberg H, Selker RG, Vick NA, Rampling R, Friedman H, Phillips P, Bruner J, Yue N, Osoba D, Zaknoen S, Levin VA: A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse. Br J Cancer 83: 588-593, 2000
13. Janinis J, Efstathiou E, Panopoulos C, Samantas E, Aravantinos G, Christodoulou C, Skarlos D: Phase II study of temozolomide in patients with relapsing high grade glioma and poor performance status. Med Oncol 17: 106-110, 2000
14. Newlands ES, O'Reilly SM, Glaser MG, Bower M, Evans H, Brock C, Brampton MH, Colquhoun I, Lewis P, Rice-Edwards JM, Illingworth RD, Richards PG: The Charing Cross Hospital experience with temozolomide in patients with gliomas. Eur J Cancer 32A: 2236-2241, 1996
15. van Rijn J, Heimans JJ, van den Berg J, van der Valk P, Slotman BJ: Survival of human glioma cells treated with various combination of temozolomide and X-rays. Int J Radiat Oncol Biol Phys 47: 779-784, 2000
16. Wedge SR, Porteous JK, Glaser MG, Marcus K, Newlands ES: In vitro evaluation of temozolomide combined with X-irradiation. Anticancer Drugs 8: 92-97, 1997
17. Stupp R, Dietrich PY, Ostermann Kraljevic S, Pica A, Maillard I, Maeder P, Meuli R, Janzer R, Pizzolato, G, Miralbell R, Porchet F, Regli L, de Tribolet N, Mirimanoff RO, Leyvraz S: Promising survival for patients with newly diagnosed glioblastoma multiforme treated with concomitant radiation plus temozolomide followed by adjuvant temozolomide. J Clin Oncol 20: 1375-1382, 2002
18. Brandes AA, Ermani M, Basso U, Paris MK, Lumachi F, Berti F, Amista P, Gardiman M, Iuzzolino P, Turazzi S, Monfardini S: Temozolomide in patients with glioblastoma at second relapse after first line nitrosourea-procarbazine failure: a phase II study. Oncology 63: 38-41, 2002
19. Groves MD, Puduvalli VK, Hess KR, Jaeckle KA, Peterson P, Yung WK, Levin VA: Phase II trial of temozolomide plus the matrix metalloproteinase inhibitor, marimastat, in recurrent and progressive glioblastoma multiforme. J Clin Oncol 20: 1383-1388, 2002
20. Brada M, Hoang-Xuan K, Rampling R, Dietrich PY, Dirix LY, Macdonald D, Heimans JJ, Zonnenberg BA, Bravo-Marques JM, Henriksson R, Stupp R, Yue N, Bruner J, Dugan M, Rao S, Zaknoen S: Multicenter phase II trial of temozolomide in patients with glioblastoma multiforme at first relapse. Ann Oncol 12: 259-266, 2001
21. Brandes AA, Ermani M, Basso U, Amista P, Berti F, Scienza R, Rotilio A, Pinna G, Gardiman M, Monfardini S: Temozolomide as a second-line systemic regimen in recurrent high-grade glioma: a phase II study. Ann Oncol 12: 255-257, 2001
22. Harris MT, Rosenthal MA, Ashley DL, Cher L: An Australian experience with temozolomide for the treatment of recurrent high grade gliomas. J Clin Neurosci 8: 325-327, 2001
23. Yung WK, Prados MD, Yaya-Tur R, Rosenfeld SS, Brada M, Friedman HS, Albright R, Olson J, Chang SM, O'Neill AM, Friedman AH, Bruner J, Yue N, Dugan M, Zaknoen S, Levin VA: Multicenter phase II trial of temozolomide in patients with anaplastic astrocytoma or anaplastic oligoastrocytoma at first relapse. Temodal Brain Tumor Group. J Clin Oncol 17: 2762-2771, 1999
24. Kumar AJ, Leeds NE, Fuller GN, Van-Tassel P, Maor MH, Sawaya RE, Levin VA: Malignant gliomas: MR imaging spectrum of radiation therapy- and chemotherapy-induced necrosis of the brain after treatment. Radiology 217: 377-384, 2000
25. Biousse V, Newman NJ, Hunter SB, Hudgins PA: Diffusion weighted imaging in radiation necrosis. J Neurol Neurosurg Psychiatry 74: 382-384, 2003
26. Bauman GS, Sneed PK, Wara WM, Stalpers LJ, Chang SM, McDermott MW, Gutin PH, Larson DA: Reirradiation of primary CNS tumors. Int J Radiat Oncol Biol Phys 36: 433-441, 1996
27. Kim HK, Thornton AF, Greenberg HS, Page MA, Junck L, Sandler HM: Results of re-irradiation of primary intracranial neoplasms with three- dimensional conformal therapy. Am J Clin Oncol 20: 358-363, 1997
28. Hayat K, Jones B, Bisbrown G, Baria K, Pigott T: Retreatment of patients with intracranial gliomas by external beam radiotherapy and cytotoxic chemotherapy. Clin Oncol (R Coll Radiol) 9: 158-163, 1997
29. Arcicasa M, Roncadin M, Bidoli E, Dedkov A, Gigante M, Trovo MG: Reirradiation and lomustine in patients with relapsed high-grade gliomas. Int J Radiat Oncol Biol Phys 43: 789-793, 1999
30. Shepherd SF, Laing RW, Cosgrove VP, Warrington AP, Hines F, Ashley SE, Brada M: Hypofractionated stereotactic radiotherapy in the management of recurrent glioma. Int J Radiat Oncol Biol Phys 37: 393-398, 1997
31. Hudes RS, Corn BW, Werner-Wasik M, Andrews D, Rosenstock J, Thoron L, Downes B, Curran WJ Jr.: A phase I dose escalation study of hypofractionated steremactic radiotherapy as salvage therapy for persistent or recurrent malignant glioma. Int J Radiat Oncol Biol Phys 43: 293-298, 1999
32. Lederman G, Wronski M, Arbit E, Odaimi M, Wertheim S, Lombardi E, Wrzolek M: Treatment of recurrent glioblastoma multiforme using fractionated stereotactic radiosurgery and concurrent paclitaxel. Am J Clin Oncol 23: 155-159, 2000
33. Glass J, Silverman CL, Axelrod R, Corn BW, Andrews DW: Fractionated stereotactic radiotherapy with cis-platinum radiosensitization in the treatment of recurrent, progressive, or persistent malignant astrocytoma. Am J Clin Oncol 20: 226-229, 1997
34. Shaw E, Scott C, Souhami L, Dinapoli R, Bahary JP, Kline R, Wharam M, Schultz C, Davey P, Loeffler J, Del-Rowe J, Marks L, Fisher B, Shin K: Radiosurgery for the treatment of previously irradiated recurrent primary brain tumors and brain metastases: initial report of radiation therapy oncology group protocol (90-05). Int J Radiat Oncol Biol Phys 34: 647-654, 1996
35. van-Kampen M, Engenhart-Cabillic R, Debus J, Fuss M, Rhein B, Wannenmacher M: The value of radiosurgery for recurrent glioblastoma multiforme. Strahlenther Onkol 174: 19-24, 1998
36. Shrieve DC, Alexander E 3rd, Wen PY, Fine HA, Kooy HM, Black PM, Loeffler JS: Comparison of stereotactic radiosurgery and brachytherapy in the treatment of recurrent glioblastoma multiforme. Neurosurgery 36: 275-282; discussion 282-274, 1995
37. Gaspar LE, Zamorano LJ, Shamsa F, Fontanesi J, Ezzell GE, Yakar DA: Permanent 125iodine implants for recurrent malignant gliomas. Int J Radiat Oncol Biol Phys 43: 977-982, 1999
38. Silbergeld DL, Griffin BR, Ojemann GA: Reirradiation for recurrent cerebral astrocytoma. J Neuro-Oncol 12: 145-151, 1992
39. Veninga T, Langendijk HA, Slotman BJ, Rutten EH, van-der-Kogel AJ, Prick MJ, Keyser A, van-der-Maazen RW: Reirradiation of primary brain tumours: survival, clinical response and prognostic factors. Radiother Oncol 59: 127-137, 2001
40. Bower M, Newlands ES, Bleehen NM, Brada M, Begent RJ, Calvert H, Colquhoun I, Lewis P, Brampton MH: Multicentre CRC phase II trial of temozolomide in recurrent or progressive high-grade glioma. Cancer Chemother Pharmacol 40: 484-488, 1997
41. Poisson M, Pereon Y, Chiras J, Delattre JY: Treatment of recurrent malignant supratentorial gliomas with carboplatin (CBDCA). J Neuro-Oncol 10: 139-144, 1991
42. Ameri A, Poisson M, Chauveinc L, Chen QM, Delattre JY: Treatment of recurrent malignant supratentorial gliomas with the association of carboplatin and etoposide: a phase II study. J Neuro-Oncol 32: 155-160, 1997
43. van-den-Bent MJ, Schellens JH, Vecht CJ, Sillevis-Smit PA, Loosveld OJ, Ma J, Tijssen CC, Jansen RL, Kros JM, Verweij J: Phase II study on cisplatin and ifosfamide in recurrent high grade gliomas. Eur J Cancer (Oxford, England: 1990) 34: 1570-1574, 1998
44. Brandes AA, Scelzi E, Zampieri P, Rigon A, Rotilio A, Amista P, Berti F, Fiorentino MV: Phase II trial with BCNU plus alpha-interferon in patients with recurrent high-grade gliomas. Amer J Clin Oncol 20: 364-367, 1997
45. Rostomily RC, Spence AM, Duong D, McCormick K, Bland M, Berger MS: Multimodality management of recurrent adult malignant gliomas: results of a phase II multiagent chemotherapy study and analysis of cytoreductive surgery. Neurosurgery 35: 378-388; discussion 388, 1994
46. Galanis E, Buckner JC, Burch PA, Schaefer PL, Dinapoli RP, Novotny PJ, Scheithauer BW, Rowland KM, Vukov AM, Mailliard JA, Morton RF: Phase II trial of nitrogen mustard, vincristine, and procarbazine in patients with recurrent glioma: North Central Cancer Treatment Group results. J Clin Oncol 16: 2953-2958, 1998
47. Clarke K, Basser RL, Underhill C, Mitchell P, Bartlett J, Cher L, Findlay M, Dalley D, Pell M, Byrne M, Geldard H, Hill JS, Maher D, Fox RM, Green MD, Kaye AH: KRN8602 (MX2-hydrochloride): an active new agent for the treatment of recurrent high-grade glioma. J Clin Oncol 17: 2579-2584, 1999
48. Friedman HS, Petros WP, Friedman AH, Schaaf LJ, Kerby T, Lawyer J, Parry M, Houghton PJ, Lovell S, Rasheed K, Cloughsey T, Stewart ES, Colvin OM, Provenzale JM, McLendon RE, Bigner DD, Cokgor I, Haglund M, Rich J, Ashley D, Malczyn J, Elfring GL, Miller LL: Irinotecan therapy in adults with recurrent or progressive malignant glioma. J Clin Oncol: the official journal of the American Society Clinical Oncology 17: 1516-1525, 1999
49. Phuphanich S, Scott C, Fischbach AJ, Langer C, Yung WK: All-trans-retinoic acid: a phase II Radiation Therapy Oncology Group study (RTOG 91-13) in patients with recurrent malignant astrocytoma. J Neuro-Oncol 34: 193-200, 1997
50. Bleehen NM, Freedman LS, Stenning SP: A randomized study of CCNU with and without benznidazole in the treatment of recurrent grades 3 and 4 astrocytoma. Report to the Medical Research Council by the Brain Tumor Working Party. Int J Radiat Oncol Biol Phys 16: 1077-1081, 1989
51. Sanson M, Ameri A, Monjour A, Sahmoud T, Ronchin P, Poisson M, Delattre JY: Treatment of recurrent malignant supratentorial gliomas with ifosfamide, carboplatin and etoposide: a phase II study. Eur J Cancer 32A: 2229-2235, 1996
52. Schonekaes K, Mucke R, Panke J, Rama B, Wagner W: Combined radiotherapy and temozolomide in patients with recurrent high grade glioma. Tumori 88: 28-31, 2002